Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the potential of MEM 1003 as a safe and effective
treatment for patients with an acute manic or mixed episode of bipolar disorder.